BDTX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
BDTX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Black Diamond Therapeutics's institutional ownership is 39.59%.
Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Black Diamond Therapeutics's Insider Ownership is 2.24%.
Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Black Diamond Therapeutics's Float Percentage Of Total Shares Outstanding is 59.19%.
The historical data trend for Black Diamond Therapeutics's Institutional Ownership can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Black Diamond Therapeutics Historical Data
The historical data trend for Black Diamond Therapeutics can be seen below:
2023-07-31 | 2023-08-31 | 2023-09-30 | 2023-10-31 | 2023-11-30 | 2023-12-31 | 2024-01-31 | 2024-02-29 | 2024-03-31 | 2024-04-30 | |
Institutional Ownership | 28.15 | 28.00 | 32.80 | 31.51 | 31.53 | 35.38 | 35.42 | 34.79 | 39.69 | 39.59 |
The percentage of shares that are owned by institutions out of the total shares outstanding.
Biotech Growth N V | 10 percent owner | ARA HILL TOP BUILDING, UNIT A-5, PLETTERIJWEG OOST 1, CURACAO, WILLEMSTAD P8 000000 |
Ra Capital Nexus Fund, L.p. | director | 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116 |
Ali Behbahani | director, 10 percent owner | 5425 WISCONSIN AVE, CHEVY CHASE MD 20815 |
Peter Kolchinsky | director | 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116 |
Ra Capital Management, L.p. | director | 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116 |
Ra Capital Healthcare Fund Lp | director | 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116 |
David M. Epstein | director, officer: See Remarks | OSI PHARMACEUTICALS, INC., 41 PINELAWN ROAD, MELVILLE NY 11747 |
Sergey Yurasov | officer: CHIEF MEDICAL OFFICER | C/O IMMUNE DESIGN CORP., 1616 EASTLAKE AVE. E., SUITE 310, SEATTLE WA 98102 |
Elizabeth Buck | officer: CHIEF SCIENTIFIC OFFICER | C/O BLACK DIAMOND THERAPEUTICS, INC., ONE MAIN STREET, 10TH FLOOR, CAMBRIDGE MA 02142 |
Erika Jones | officer: SEE REMARKS | C/O BLACK DIAMOND THERAPEUTICS, INC., ONE MAIN STREET, 10TH FLOOR, CAMBRIDGE MA 02142 |
Fang Ni | officer: SEE REMARKS | C/O BLACK DIAMOND THERAPEUTICS, INC., ONE MAIN STREET, 10TH FLOOR, CAMBRIDGE MA 02142 |
Biotech Ag Bb | 10 percent owner | SCHWERTSTRASSE 6, SCHAFFHAUSEN V8 8200 |
Wendy L Dixon | director | |
Mark A. Velleca | director | 79 TW ALEXANDER DRIVE, 4501 RESEARCH COMMONS, SUITE 100, RESEARCH TRIANGLE PARK NC 27709 |
Brent Hatzis-schoch | officer: See Remarks | C/O RADIUS HEALTH, INC., 950 WINTER STREET, WALTHAM MA 02451 |
From GuruFocus
By PurpleRose PurpleRose • 08-03-2022
By Marketwired • 11-07-2023
By sperokesalga sperokesalga • 05-09-2023
By PurpleRose PurpleRose • 07-11-2022
By GlobeNewswire • 10-14-2023
By PurpleRose PurpleRose • 07-11-2022
By Value_Insider Value_Insider • 12-19-2022
By sperokesalga sperokesalga • 06-02-2023
By Value_Insider Value_Insider • 12-12-2022
By sperokesalga sperokesalga • 06-13-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.